FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

T Sálek

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
J Mardiak; T Sálek; Z Sycová-Milá; J Obertová; M Recková; Michal Mego; Z Hlavatá; K Brozmanová; Z Risnyovzská; D Svetlovská; I Koza
Paclitaxel, bleomycin, etoposide, and cisplatin (T-BEP) as initial treatment in patients with poor-prognosis germ cell tumors (GCT): a phase II study.
J Mardiak; T Sálek; Z Sycová-Milá; J Obertová; Z Hlavatá; Michal Mego; M Recková; I Koza
Paclitaxel plus ifosfamide and cisplatin in second-line treatment of germ cell tumors: a phase II study.
J Mardiak; T Sálek; Z Sycová-Milá; J Obertová; Z Hlavatá; Michal Mego; M Recková; I Koza
Gemcitabine plus cisplatine and paclitaxel (GCP) in second-line treatment of germ cell tumors (GCT): a phase II study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of T Sálek (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: J Mardiak; T Sálek; Z Sycová-Milá; J Obertová; M Recková; Michal Mego; Z Hlavatá; K Brozmanová; Z Risnyovzská; D Svetlovská; I Koza
Paclitaxel, bleomycin, etoposide, and cisplatin (T-BEP) as initial treatment in patients with poor-prognosis germ cell tumors (GCT): a phase II study.
Neoplasma 2007;54(3):240-5.
2005: J Mardiak; T Sálek; Z Sycová-Milá; J Obertová; Z Hlavatá; Michal Mego; M Recková; I Koza
Paclitaxel plus ifosfamide and cisplatin in second-line treatment of germ cell tumors: a phase II study.
Neoplasma 2005;52(6):497-501.
2005: J Mardiak; T Sálek; Z Sycová-Milá; J Obertová; Z Hlavatá; Michal Mego; M Recková; I Koza
Gemcitabine plus cisplatine and paclitaxel (GCP) in second-line treatment of germ cell tumors (GCT): a phase II study.
Neoplasma 2005;52(3):243-7.
2000: J Mardiak; L Bohunický; J Chovanec; T Sálek; I Koza
Adjuvant clodronate therapy in patients with locally advanced breast cancer--long term results of a double blind randomized trial. Slovak Clodronate Collaborative Group.
Neoplasma 2000;47(3):177-80.
2000: J Mardiak; T Sálek; Z Sycova-Milá; J Sufliarsky; M Baláz; I Koza
Carboplatin and cyclophosphamide in the treatment of metastatic seminoma.
Neoplasma 2000;47(4):244-7.
2000: J Mardiak; P Fuchsberger; J Lakota; T Sálek; Z Sycová-Milá; M Drahokoupilová; M Baláz; I Koza
Sequential intermediate high-dose therapy with etoposide, ifosfamide and cisplatin for patients with germ cell tumors.
Neoplasma 2000;47(4):239-43.
1998: Vladimir Krcméry; S Spánik; S Grausová; Jan Trupl; I Krupová; A Roidová; T Sálek; J Sufliarsky; J Mardiak
Candida parapsilosis fungemia in cancer patients--incidence, risk factors and outcome.
Neoplasma 1998;45(5):336-42.